Asia Pacific Medical Second Opinion Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Disorders (Cancer, Orthopedic Disorders, Cardiac Disorders, Neurological Disorders, Nephrological Disorders, Hematologic Blood Disorders, COPD, Organ Transplant, and Others) and Service Providers (Hospitals, Health Insurance Companies, and Online Services)

No. of Pages: 113    |    Report Code: TIPRE00025235    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Medical Second Opinion Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Medical Second Opinion Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Medical Second Opinion Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing emphasis on better treatment outcomes Favors Market Growth
5.2 Market Opportunities
  • 5.2.1 Increasing collaborations in telemedicine technologies are likely to create ample opportunities in the coming years
5.3 Future Trends
  • 5.3.1 Increasing digitalization of medical consulting services expected to be the future trends in coming years
5.4 Impact of Drivers and Restraints

6. Asia Pacific Medical Second Opinion Market Regional Analysis

6.1 Asia Pacific Medical Second Opinion Market Overview
6.2 Asia Pacific Medical Second Opinion Market Revenue 2018-2027 (US$ Million)
6.3 Asia Pacific Medical Second Opinion Market Forecast Analysis

7. Asia Pacific Medical Second Opinion Market Analysis – by Disorders

7.1 Cancer
  • 7.1.1 Overview
  • 7.1.2 Cancer: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Orthopedic Disorders
  • 7.2.1 Overview
  • 7.2.2 Orthopedic Disorders: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cardiac Disorders
  • 7.3.1 Overview
  • 7.3.2 Cardiac Disorders: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Neurological Disorders
  • 7.4.1 Overview
  • 7.4.2 Neurological Disorders: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Nephrological Disorders
  • 7.5.1 Overview
  • 7.5.2 Nephrological Disorders: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Hematologic Blood Disorders
  • 7.6.1 Overview
  • 7.6.2 Hematologic Blood Disorders: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.7 COPD
  • 7.7.1 Overview
  • 7.7.2 COPD: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Organ Transplant
  • 7.8.1 Overview
  • 7.8.2 Organ Transplant: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Medical Second Opinion Market Analysis – by Service Providers

8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Hospitals: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Health Insurance Companies
  • 8.2.1 Overview
  • 8.2.2 Health Insurance Companies: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Online Services
  • 8.3.1 Overview
  • 8.3.2 Online Services : Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Medical Second Opinion Market – Asia-Pacific Analysis

9.1 Asia-Pacific
  • 9.1.1 Asia Pacific Medical Second Opinion Market Breakdown, by Key Country, 2021 and 2027 (%)
  • 9.1.1.1 Asia Pacific Medical Second Opinion Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 China: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.1.1 China: Asia Pacific Medical Second Opinion Market Breakdown, by Disorders
    • 9.1.1.1.2 China: Asia Pacific Medical Second Opinion Market Breakdown, by Service Providers
  • 9.1.1.2 India: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.2.1 India: Asia Pacific Medical Second Opinion Market Breakdown, by Disorders
    • 9.1.1.2.2 India: Asia Pacific Medical Second Opinion Market Breakdown, by Service Providers
  • 9.1.1.3 Japan: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.3.1 Japan: Asia Pacific Medical Second Opinion Market Breakdown, by Disorders
    • 9.1.1.3.2 Japan: Asia Pacific Medical Second Opinion Market Breakdown, by Service Providers
  • 9.1.1.4 Australia: Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.4.1 Australia: Asia Pacific Medical Second Opinion Market Breakdown, by Disorders
    • 9.1.1.4.2 Australia: Asia Pacific Medical Second Opinion Market Breakdown, by Service Providers
  • 9.1.1.5 Rest of Asia-Pacific : Asia Pacific Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Medical Second Opinion Market Breakdown, by Disorders
    • 9.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Medical Second Opinion Market Breakdown, by Service Providers

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Asia Pacific Medical Second Opinion Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Medisense Healthcare Solutions Pvt. Ltd
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Second Opinion International
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Cigna
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 WorldCare
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Vidal Health Insurance TPA Pvt Ltd
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Medix
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 AXA
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - Asia Pacific Medical Second Opinion Market

  1. Medisense Healthcare Solutions Pvt. Ltd
  2. Second Opinion International
  3. Cigna
  4. WorldCare
  5. Vidal Health Insurance TPA Pvt Ltd
  6. Medix
  7. AXA